Oral bioavailability technology regulatory update

The University of California (Oakland, Calif.) received U.S. Patents Nos. 6,004,927 and 6,028,054 covering the use of inhibitors of cytochrome P450 3A ( CYP3A) or P-glycoprotein (Pgp), respectively, ...